SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-005920
Filing Date
2020-01-22
Accepted
2020-01-22 16:09:57
Documents
13
Period of Report
2020-01-22
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205443-3_8k.htm   iXBRL 8-K 31086
2 EXHIBIT 99.1 tm205443d3_ex99-1.htm EX-99.1 8143
  Complete submission text file 0001104659-20-005920.txt   217231

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imgn-20200122.xsd EX-101.SCH 3189
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imgn-20200122_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imgn-20200122_pre.xml EX-101.PRE 22712
9 EXTRACTED XBRL INSTANCE DOCUMENT tm205443-3_8k_htm.xml XML 3469
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 20539034
SIC: 2834 Pharmaceutical Preparations